Access expanded to COVID-19 antiviral including Pfizer's COVID-19 oral antiviral for more Kiwis at risk of severe infection from COVID-19

Effective 1 October 2023, Pharmac has expanded access to COVID-19 antiviral treatments for people who are vulnerable to severe illness following COVID-19 infection, including disabled people and people with one or more severe health conditions that have resulted in severe frailty or vulnerability

Related Keywords

New Zealand , New Zealanders , Huhana Hickey , Disability Support Services , Ministry Of Health , Ministry Of Disabled People , Disabled People , Pfizer Australia , New Zealand Medical Director , Critical Care , High Dependency ,